To define nurse managers' organizational silence behaviors and examine the demographic, occupational, and practice environment factors that may influence their silence. Background: Organizational silence is affected by organizational structures, policies and procedures, team structures, and practice environments. Whether nurse managers' behaviors affect the organizational silence and practice environment in particular has not been thoroughly studied. Methods: This cross-sectional study was conducted using an online survey of 169 nurse managers working in a group of private hospitals in Turkey. Data were collected using the Nurse Manager Practice Environment Scale, the Organizational Silence Behavior Scale, and a questionnaire with 16 sociodemographic and job-related questions, and descriptive statistics, correlations, and regression analyses were used to analyze the data. Results: Nurse managers exhibited acquiescent silence and silence for the protection of the organization. There was a negative correlation between scores on the two scales. Regression analysis showed that nurse managers' organizational silence was affected by the two subscales of nurse managers' practice environment and the ability to express opinions openly. Conclusion:Positive work environment and being able to express opinions comfortably decrease the level of organizational silence of nurse managers. Implications for nursing and health policy: In order to reduce organizational silence behaviors, along with open-door policies and a corporate culture where ideas can be expressed freely, health institutions should implement measures to ensure a positive work environment that empowers administrative leaders to create a culture of patient safety and culture of generativity. Regulating the roles and responsibilities of nurse managers at the institutional level and implementing appropriate nursing laws and regulations at the national level will facilitate changes to improve their management practices.

It was designed as a retrospective study. Between January 2018 and June 2021, 590 patients who developed pressure ulcers from 16 hospitals affiliated with Acıbadem Healthcare Group (AHG) were identified and classified as Stage 1, Stage 2, Stage 3, Stage 4 and Unstageable pressure ulcer, suspected of deep tissue damage. The cost of treatment was calculated in each category and the total cost per patient for the company was determined. There are two main ways to get data for analysis; 1- Sentinel Event System Reports (for determining the number of patients with pressure ulcers) and 2- Patient Services Pricing Department (for defining the cost of treatment). Costs and costing given by the pricing department with a bottom-up approach are calculated from the patient perspective. Pressure sore cost calculation for COVID-19 patients covers the period from March 2020 to June 2021. Data analysis: Two main ways were used to collect data for analysis; 1- Sentinel Event Notification System Reports (for determining the number of patients with pressure ulcers) and 2- Patient Services Pricing Department (for defining the cost of treatment). Population: All patients who developed pressure ulcers in 16 hospitals affiliated to Acıbadem Healthcare Group since 2018

No abstract